These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33213388)

  • 1. Characterization of an N-terminal Na
    Scheiper-Welling S; Zuccolini P; Rauh O; Beckmann BM; Geisen C; Moroni A; Thiel G; Kauferstein S
    BMC Med Genet; 2020 Nov; 21(1):227. PubMed ID: 33213388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCN5A variant that blocks fibroblast growth factor homologous factor regulation causes human arrhythmia.
    Musa H; Kline CF; Sturm AC; Murphy N; Adelman S; Wang C; Yan H; Johnson BL; Csepe TA; Kilic A; Higgins RS; Janssen PM; Fedorov VV; Weiss R; Salazar C; Hund TJ; Pitt GS; Mohler PJ
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12528-33. PubMed ID: 26392562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
    Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
    PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SCN5A-C683R exhibits combined gain-of-function and loss-of-function properties related to adrenaline-triggered ventricular arrhythmia.
    Steinberg C; Pilote S; Philippon F; Laksman ZW; Champagne J; Simard C; Krahn AD; Drolet B
    Exp Physiol; 2021 Mar; 106(3):683-699. PubMed ID: 33480457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A distinct molecular mechanism by which phenytoin rescues a novel long QT 3 variant.
    Gando I; Campana C; Tan RB; Cecchin F; Sobie EA; Coetzee WA
    J Mol Cell Cardiol; 2020 Jul; 144():1-11. PubMed ID: 32339567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant Brugada-like and short QT electrocardiogram linked to SCN5A mutation.
    Hong K; Hu J; Yu J; Brugada R
    Eur J Hum Genet; 2012 Nov; 20(11):1189-92. PubMed ID: 22490985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents.
    Hu D; Barajas-Martínez H; Medeiros-Domingo A; Crotti L; Veltmann C; Schimpf R; Urrutia J; Alday A; Casis O; Pfeiffer R; Burashnikov E; Caceres G; Tester DJ; Wolpert C; Borggrefe M; Schwartz P; Ackerman MJ; Antzelevitch C
    Heart Rhythm; 2012 May; 9(5):760-9. PubMed ID: 22155597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infant sudden death: Mutations responsible for impaired Nav1.5 channel trafficking and function.
    Gando I; Morganstein J; Jana K; McDonald TV; Tang Y; Coetzee WA
    Pacing Clin Electrophysiol; 2017 Jun; 40(6):703-712. PubMed ID: 28370132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of modulatory effect of the SCN5A R1193Q polymorphism on cardiac fast Na+ current at body temperature.
    Abe M; Kinoshita K; Matsuoka K; Nakada T; Miura K; Hata Y; Nishida N; Tabata T
    PLoS One; 2018; 13(11):e0207437. PubMed ID: 30419068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
    Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
    Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of a novel SCN5A variant associated with long QT syndrome and sudden cardiac death.
    Neubauer J; Wang Z; Rougier JS; Abriel H; Rieubland C; Bartholdi D; Haas C; Medeiros-Domingo A
    Int J Legal Med; 2019 Nov; 133(6):1733-1742. PubMed ID: 31455979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel
    Monasky MM; Micaglio E; Ciconte G; Rivolta I; Borrelli V; Ghiroldi A; D'Imperio S; Binda A; Melgari D; Benedetti S; Mitrovic P; Anastasia L; Mecarocci V; Ćalović Ž; Casari G; Pappone C
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndrome.
    Beyder A; Mazzone A; Strege PR; Tester DJ; Saito YA; Bernard CE; Enders FT; Ek WE; Schmidt PT; Dlugosz A; Lindberg G; Karling P; Ohlsson B; Gazouli M; Nardone G; Cuomo R; Usai-Satta P; Galeazzi F; Neri M; Portincasa P; Bellini M; Barbara G; Camilleri M; Locke GR; Talley NJ; D'Amato M; Ackerman MJ; Farrugia G
    Gastroenterology; 2014 Jun; 146(7):1659-1668. PubMed ID: 24613995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gain-of-function mutation of the SCN5A gene causes exercise-induced polymorphic ventricular arrhythmias.
    Swan H; Amarouch MY; Leinonen J; Marjamaa A; Kucera JP; Laitinen-Forsblom PJ; Lahtinen AM; Palotie A; Kontula K; Toivonen L; Abriel H; Widen E
    Circ Cardiovasc Genet; 2014 Dec; 7(6):771-81. PubMed ID: 25210054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of Nedd4-2-binding capacity in PY-motif of Na
    Wang Y; Du Y; Luo L; Hu P; Yang G; Li T; Han X; Ma A; Wang T
    Acta Physiol (Oxf); 2020 Jun; 229(2):e13438. PubMed ID: 31900993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac sodium channel palmitoylation regulates channel availability and myocyte excitability with implications for arrhythmia generation.
    Pei Z; Xiao Y; Meng J; Hudmon A; Cummins TR
    Nat Commun; 2016 Jun; 7():12035. PubMed ID: 27337590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular calcium attenuates late current conducted by mutant human cardiac sodium channels.
    Potet F; Beckermann TM; Kunic JD; George AL
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):933-41. PubMed ID: 26022185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant voltage-gated Na
    Clatot J; Zheng Y; Girardeau A; Liu H; Laurita KR; Marionneau C; Deschênes I
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1250-H1257. PubMed ID: 30118344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCN5A(K817E), a novel Brugada syndrome-associated mutation that alters the activation gating of NaV1.5 channel.
    Kinoshita K; Takahashi H; Hata Y; Nishide K; Kato M; Fujita H; Yoshida S; Murai K; Mizumaki K; Nishida K; Yamaguchi Y; Kano M; Tabata T; Nishida N
    Heart Rhythm; 2016 May; 13(5):1113-1120. PubMed ID: 26776555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome.
    Rook MB; Bezzina Alshinawi C; Groenewegen WA; van Gelder IC; van Ginneken AC; Jongsma HJ; Mannens MM; Wilde AA
    Cardiovasc Res; 1999 Dec; 44(3):507-17. PubMed ID: 10690282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.